Paper779704
Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique.
Wålinder J and 3 others. Arch Gen Psychiatry, 1976. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique. Papers, record 779704. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/779704
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methyltyrosines | Major topic |
| Schizophrenia | Major topic |
| Thioridazine | Major topic |
| Aged | |
| Chronic Disease | |
| Clinical Trials as Topic | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Female | |
| Homovanillic Acid | |
| Humans | |
| Hydroxyindoleacetic Acid | |
| Male | |
| Middle Aged |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39562449 | The Use of Event-Related Potentials in the Study of Schizophrenia: An Overview. | Adv Neurobiol | 2024 | https://conductscience.org/library/papers/39562449 | PubMed |
| 38731862 | Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731862 | PubMed |
| 25586400 | Glutamate and dopamine in schizophrenia: an update for the 21st century. | J Psychopharmacol | 2015 | https://conductscience.org/library/papers/25586400 | PubMed |
| 17636691 | Thioridazine for schizophrenia. | Cochrane Database Syst Rev | 2007 | https://conductscience.org/library/papers/17636691 | PubMed |
| 7857586 | Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function. | J Neural Transm Gen Sect | 1994 | https://conductscience.org/library/papers/7857586 | PubMed |
| 6441943 | Effects of (-)3-PPP on acquisition and retention of a conditioned avoidance response in the rat. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6441943 | PubMed |
| 6149256 | Antipsychotic treatment with alpha-methyltyrosine in combination with thioridazine: prolactin response and interaction with dopaminergic precursor pools. | J Neural Transm | 1984 | https://conductscience.org/library/papers/6149256 | PubMed |
| 2871578 | Acute dystonia induced by neuroleptic drugs. | Psychopharmacology (Berl) | 1986 | https://conductscience.org/library/papers/2871578 | PubMed |
| 1358119 | Pharmacologic properties of (-)-3PPP (preclamol) in man. | J Neural Transm Gen Sect | 1992 | https://conductscience.org/library/papers/1358119 | PubMed |
| 703854 | Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships. | Naunyn Schmiedebergs Arch Pharmacol | 1978 | https://conductscience.org/library/papers/703854 | PubMed |
| 438807 | Dose-dependent pharmacokinetics of alpha-methyl-p-tyrosine (alpha-MT) and comparison of catecholamine turnover rates after two doses of alpha-MT. | J Neural Transm | 1979 | https://conductscience.org/library/papers/438807 | PubMed |
| 417365 | Effect of baclofen on tardive dyskinesia. | Psychopharmacology (Berl) | 1978 | https://conductscience.org/library/papers/417365 | PubMed |
| 104344 | Tolerance to alpha-methyl-p-tyrosine in rats: studies on the antagonism of amphetamine-induced motor activity and excitatory behaviour. | Psychopharmacology (Berl) | 1978 | https://conductscience.org/library/papers/104344 | PubMed |
| 41188 | Antidepressant and antipsychotic agents. | Naturwissenschaften | 1979 | https://conductscience.org/library/papers/41188 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/779704
GET https://conductscience.org/api/papers/v1/779704/authors